DURECT Corporation Watch

EX-10.4

from 10-Q 9 pages Amendment No. 2 to Exclusive License Agreement

12/34/56

EX-10.3

from 10-Q 5 pages Amendment No. 1 to Exclusive License Agreement

12/34/56

EX-10.1

from 8-K 14 pages DURECT Corporation 2000 Stock Plan

12/34/56

EX-10.1

from 8-K 10 pages Durect Corporation 2000 Stock Plan Notice of Restricted Stock Unit Grant

12/34/56

EX-10.2

from 10-Q 4 pages Sixth Amendment to Lease

12/34/56

EX-10.1

from 10-Q 4 pages Addendum IV to Standard Industrial/Commercial Multi-Tenant Lease - Gross

12/34/56

EX-10.1

from 8-K 38 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 12 pages Durect Corporation 2000 Employee Stock Purchase Plan

12/34/56

EX-10

from 10-K 2 pages Jb/Nb Accepted: /S/ Judith Joice 31 Mar 14 Judith Joice Date

12/34/56

EX-10

from 10-K 3 pages (24 - Months of Employment) X (Sign-On Bonus) 24

12/34/56

EX-10.1

from 8-K 35 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 10-Q 2 pages First Amendment to License Agreement

12/34/56

EX-10.1

from 8-K 2 pages Via Electronic Delivery

12/34/56

EX-10.1

from 8-K 14 pages Durect Corporation 2000 Stock Plan

12/34/56

EX-10.28

from 10-K 50 pages License Agreement by and Between Durect Corporation and Innocoll Pharmaceuticals Limited Dated December 21, 2021

12/34/56

EX-10.26

from 10-K 6 pages Agreement

12/34/56

EX-10.2

from 10-Q 7 pages Certain Information Identified by Bracketed Asterisks ([***]) Has Been Omitted and Filed Separately With the Securities and Exchange Commission. Confidential Treatment Has Been Requested With Respect to the Omitted Information

12/34/56

EX-10.1

from 10-Q 6 pages Amendment No. 1 to Exclusive License Agreement

12/34/56

EX-10.33

from 10-K 8 pages Durect Corporation Executive Change of Control Policy

12/34/56

EX-10.32

from 10-K 58 pages Asset Purchase Agreement by and Between Durect Corporation and Evonik Corporation as of December 4, 2020

12/34/56